Neurotrophic factors and the pathophysiology of schizophrenic psychoses

European Psychiatry - Tập 19 - Trang 326-337 - 2004
Nuria Durany1, Johannes Thome2
1Faculty of Health Science, International University of Catalonia, c// Josep Trueta s/n, 08190 San Cugat del Vallès (Barcelona), Spain
2Central Institute of Mental Health (ZI) Mannheim, University of Heidelberg, Germany

Tóm tắt

AbstractThe aim of this review is to summarize the present state of findings on altered neurotrophic factor levels in schizophrenic psychoses, on variations in genes coding for neurotrophic factors, and on the effect of antipsychotic drugs on the expression level of neurotrophic factors. This is a conceptual paper that aims to establish the link between the neuromaldevelopment theory of schizophrenia and neurotrophic factors. An extensive literature review has been done using the Pub Med database, a service of the National Library of Medicine, which includes over 14 million citations for biomedical articles back to the 1950s. The majority of studies discussed in this review support the notion of alterations of neurotrophic factors at the protein and gene level, respectively, and support the hypothesis that these alterations could, at least partially, explain some of the morphological, cytoarchitectural and neurobiochemical abnormalities found in the brain of schizophrenic patients. However, the results are not always conclusive and the clinical significance of these alterations is not fully understood. It is, thus, important to further neurotrophic factor research in order to better understand the etiopathogenesis of schizophrenic psychoses and, thus, potentially develop new treatment strategies urgently needed for patients suffering from these devastating disorders.

Tài liệu tham khảo

Shenton, 1992, Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study, New Engl J Med, 327, 604, 10.1056/NEJM199208273270905 10.1016/0006-8993(94)91857-0 10.1192/S0007125000293148 10.1016/0166-2236(91)90097-E 10.1038/ng0894-460a Wozniak, 1993, Brain-derived neurotrophic factor (BDNF): role in neuronal development and survival, Folia Morphol (Warsz), 52, 173 10.1038/sj.mp.4001221 10.1016/S0165-1781(01)00294-3 10.1111/j.1460-9568.1994.tb00559.x 10.1016/S0140-6736(95)91386-6 10.1038/sj.mp.4001308 10.1038/ng0595-41 10.1016/S0920-9964(98)00071-1 10.1016/S0920-9964(00)00106-7 10.1016/S0165-1781(02)00127-0 10.1523/JNEUROSCI.20-11-04030.2000 10.1016/S0165-1781(97)00035-8 10.1111/j.1750-3639.1999.tb00234.x Winter, 1995, A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury, Proc Natl Acad Sci USA, 92, 5865, 10.1073/pnas.92.13.5865 10.1097/00001756-199605310-00018 10.1016/0304-3940(95)11433-W 10.1126/science.270.5236.593 10.1097/00001756-199804200-00005 Takahashi, 1994, A null mutation in the human CNTF gene is not causally related to neurological diseases, Nat Genet, 7, 79, 10.1038/ng0594-79 10.1192/bjp.158.5.615 10.1016/j.neulet.2003.08.004 10.1016/0006-8993(95)00573-9 10.1002/(SICI)1096-8628(19970919)74:5<497::AID-AJMG8>3.0.CO;2-L 10.1016/S0304-3940(98)00807-6 10.1016/0920-9964(95)00013-C 10.1523/JNEUROSCI.13-02-00733.1993 10.1192/bjp.169.2.253a 10.1007/BF01248936 10.1111/j.1600-0447.1994.tb05830.x Conover, 1995, Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT-4, Nature, 375, 235, 10.1038/375235a0 10.1097/00001756-199607080-00019 10.1016/S0959-4388(98)80019-6 10.1093/hmg/1.5.353-a Nawa, 2000, Cytokine and growth factor involvement in schizophrenia-support for the developmental model, Mol Psychiatry, 5, 594, 10.1038/sj.mp.4000730 10.1038/381702a0 10.1006/cyto.1996.0026 10.1074/jbc.270.18.10915 10.1016/S0165-1781(97)00039-5 10.1016/S0006-8993(99)01501-2 Ockel, 1995, Neurotrophine: Überlebensfaktoren für Nervenzellen, Neuroforum, 3, 31, 10.1515/nf-1995-0305 10.1016/S0165-1781(97)00116-9 10.1523/JNEUROSCI.18-24-10700.1998 Nimgaonkar, 1995, Lack of association of schizophrenia with the neurotrophin-3 gene locus, Acta Psychiatr Scand, 92, 464, 10.1111/j.1600-0447.1995.tb09614.x 10.1016/0955-0674(90)90155-8 10.1523/JNEUROSCI.15-11-07539.1995 Nawa, 2003, Contribution of neurotrophic factors and cytokines to schizophrenia, Nippon Rinsho, 61, 521 10.1111/j.1600-0447.1998.tb10043.x Gill, 1996, Neurotrophin-3 gene polymorphism and schizophrenia: no evidence for linkage or association, Psychiatr Genet, 6, 183, 10.1097/00041444-199624000-00002 10.1016/S0006-8993(99)02067-3 10.1111/j.1600-0447.1995.tb09607.x 10.1016/0301-0082(94)90075-2 10.1016/S0920-9964(00)00084-0 Thome, 1997, Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population, Psychiatry Res, 7, 79 10.1038/1137 10.1093/hmg/2.9.1511-a 10.1016/0306-4522(94)00546-H 10.1002/ana.410260402 Perez-Polo, 1978, Levels of serum nerve growth factor in schizophrenia, Birth Defects, 14, 311 Cohen, 1996, The thalamus as a site of action of antipsychotic drugs, Am J Psychiatry, 153, 104, 10.1176/ajp.153.1.104 10.1016/S0006-3223(01)01083-6 10.1176/ajp.155.8.1049 10.1073/pnas.91.20.9593 10.1097/00008877-200006000-00007 10.1016/S0140-6736(95)92285-7 10.1001/archpsyc.1991.01810340013002 10.1007/BF02815126 Bogerts, 1993, Hippocampus-amygdale volumes and psychopathology in chronic schizophrenia, Biol Psychiatry, 33, 236, 10.1016/0006-3223(93)90289-P Cassacia-Bonnefil, 1999, Neurotrophins in cell survival/death decisions, Adv Exp Med Biol, 468, 275, 10.1007/978-1-4615-4685-6_22 10.1016/S0169-328X(98)00286-1 10.1038/39885 10.1006/dbio.1998.8955 10.1002/(SICI)1096-8628(19970725)74:4<443::AID-AJMG17>3.0.CO;2-I 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M 10.1001/archpsyc.1995.03950220039008 Arnold, 1995, Smallerneuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions, Am J Psychiatry, 152, 738, 10.1176/ajp.152.5.738 10.1001/archpsyc.1991.01810310043008 10.1006/mcne.1996.0053 10.1016/S0278-5846(01)00159-2 10.1016/S0306-4522(98)00553-3 10.1038/ng0696-143 10.1016/0169-328X(94)90160-0 10.1016/0896-6273(90)90166-D 10.1523/JNEUROSCI.16-02-00675.1996 10.1016/S1359-6101(01)00012-0 10.1046/j.1460-9568.2000.00219.x 10.1097/00001756-200312020-00010 10.1016/S0925-4927(02)00122-1 Krebs, 2000, Brain-derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia, Mol Psychiatry, 5, 558, 10.1038/sj.mp.4000749 10.1016/j.brainres.2003.09.040 10.1001/archpsyc.1993.01820150007001 10.1097/00041444-199621000-00003 10.1002/j.1460-2075.1992.tb05130.x 10.1073/pnas.91.23.11133 10.1007/BF01249090 10.1111/j.1460-9568.1994.tb00312.x 10.1016/0955-0674(95)80022-0 Franzek, 1995, A study of genetic heterogeneity in schizophrenia, Int Psychiatry Today, 4, 9 Maness, 1994, The neurotrophins and their receptors: structure, function and neuropathology, Neurosci Biobehav Rev, 18, 143, 10.1016/0149-7634(94)90043-4 10.1016/0896-6273(89)90040-8 10.1038/88158 10.1016/0166-2236(95)93922-K Klyushnik, 1999, Changes in the serum levels of autoantibody to nerve growth factor in patients with schizophrenia, Neurosci Behav Physiol, 29, 355, 10.1007/BF02465349 10.1002/cne.903560306 10.1046/j.1460-9568.2001.01633.x 10.1006/geno.1993.1226 10.1093/schbul/17.4.597 10.1016/S0165-1781(98)00076-6 Nothen, 1996, CNTF and psychiatric disorders, Nat Genet, 12, 123 10.1523/JNEUROSCI.13-07-02739.1993 10.1007/BF02245602 10.1016/0014-5793(92)81430-T 10.1016/0169-328X(93)90086-5 10.1038/350230a0 10.1523/JNEUROSCI.13-08-03394.1993 10.1523/JNEUROSCI.11-06-01577.1991 10.1016/0006-8993(94)90297-6 Lindholm, 1997, Neurotrophins and cerebellar development, Perspect Dev Neurobiol, 5, 83 10.1016/S0925-4927(96)03019-3 10.1016/0304-3940(94)90512-6 10.1177/0269881103174007 10.1097/00001756-199503270-00016 10.1097/00001756-199507310-00017 10.1016/S0006-3223(01)01267-7 10.1016/0092-8674(94)90048-5 10.1016/0896-6273(90)90089-X 10.1016/0009-8981(94)90132-5 10.1016/0896-6273(93)90245-M 10.1002/j.1460-2075.1990.tb07423.x 10.1007/s007020050040 Corey-Bloom, 1995, Quantitative magnetic resonance imaging of the brain in late-life schizophrenia, Am J Psychiatry, 152, 447, 10.1176/ajp.152.3.447 10.1073/pnas.90.7.2557 Lindsay, 1994, Neurotrophic factors: from molecule to man, TINS, 17, 182 10.1016/S0920-9964(02)00505-4 10.1038/sj.mp.4000718 Thome, 1997, Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyl-transferase (ChAT) and acetylcholine esterase (AChE) activities and neurotrophin-3 (NT-3) concentration in human post-mortem brain tissue, J Hirnforsch, 38, 443 10.1006/exnr.1993.1124 Kornhuber, 1994, Aktueller Stand der biochemischen Hypothesen zur Pathogenese der Schizophrenien, Nervenartz, 65, 741 10.1002/(SICI)1096-8628(19991215)88:6<724::AID-AJMG25>3.0.CO;2-7 10.1016/S0278-5846(03)00112-X 10.1038/nrn1078 10.1006/bbrc.1995.1531 Horton, 1996, Leukemia inhibitory factor and ciliary neurotrophic factor in sensory neuron development, Perspect Dev Neurobiol, 4, 358 10.1523/JNEUROSCI.20-11-04011.2000 10.1016/0955-0674(95)80073-5 10.1111/j.1600-0447.1994.tb01534.x 10.1097/00001756-199712010-00027 Pierce, 2001, The role of neurotrophic factors in psychostimulant-induced behavioural and neuronal plasticity, Res Neurosci, 12, 95 10.1016/0304-3940(92)90762-V Hattori, 2002, Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their association with schizophrenia, Am J Med Genet, 114, 304, 10.1002/ajmg.10248 10.1192/bjp.172.4.316 10.1006/nimg.1998.0387 10.1111/j.1600-0447.1997.tb09654.x
Thông tin
Thông tin xuất bản

European Psychiatry

Tập 19

326-337

Thông tin tác giả